Skip to main content
. 2021 Oct 8;11:20012. doi: 10.1038/s41598-021-99404-8

Figure 6.

Figure 6

Viral titres in transgenic mice expressing the human ACE2 protein under the human cytokeratin 18 promoter (n = 10–14) following the nasal dosing of GCPQ once daily (20 mg/kg) and intramuscular remdesivir at a single daily dose of 25 mg/kg.